These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 17347328)
1. Presence and phenotype of dendritic cells in uveal melanoma. Polak ME; Borthwick NJ; Johnson P; Hungerford JL; Higgins B; Di Palma S; Jager MJ; Cree IA Br J Ophthalmol; 2007 Jul; 91(7):971-6. PubMed ID: 17347328 [TBL] [Abstract][Full Text] [Related]
2. Presence and maturity of dendritic cells in melanoma lymph node metastases. Polak ME; Johnson P; Di Palma S; Higgins B; Hurren J; Borthwick NJ; Jager MJ; Mccormick D; Cree IA J Pathol; 2005 Sep; 207(1):83-90. PubMed ID: 15983979 [TBL] [Abstract][Full Text] [Related]
3. Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163. Woodward J; Sisley K; Reeves G; Nichols C; Parsons MA; Mudhar H; Rennie I Int J Exp Pathol; 2004 Feb; 85(1):35-43. PubMed ID: 15113392 [TBL] [Abstract][Full Text] [Related]
4. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma. Scholes AG; Hagan S; Hiscott P; Damato BE; Grierson I Arch Ophthalmol; 2001 Mar; 119(3):373-7. PubMed ID: 11231770 [TBL] [Abstract][Full Text] [Related]
6. Detection of M2-macrophages in uveal melanoma and relation with survival. Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059 [TBL] [Abstract][Full Text] [Related]
7. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068 [TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Mäkitie T; Summanen P; Tarkkanen A; Kivelä T Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040 [TBL] [Abstract][Full Text] [Related]
9. Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Shaif-Muthana M; McIntyre C; Sisley K; Rennie I; Murray A Cancer Res; 2000 Nov; 60(22):6441-7. PubMed ID: 11103811 [TBL] [Abstract][Full Text] [Related]
10. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928 [TBL] [Abstract][Full Text] [Related]
11. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells. Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of local immunosuppression in cutaneous melanoma. Polak ME; Borthwick NJ; Gabriel FG; Johnson P; Higgins B; Hurren J; McCormick D; Jager MJ; Cree IA Br J Cancer; 2007 Jun; 96(12):1879-87. PubMed ID: 17565341 [TBL] [Abstract][Full Text] [Related]
14. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma. Toivonen P; Kivelä T Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904 [TBL] [Abstract][Full Text] [Related]
15. HLA antigen expression on uveal melanoma cells in vivo and in vitro. de Waard-Siebinga I; Kool J; Jager MJ Hum Immunol; 1995 Oct; 44(2):111-7. PubMed ID: 8847229 [TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma. Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640 [TBL] [Abstract][Full Text] [Related]
17. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium? Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306 [TBL] [Abstract][Full Text] [Related]
18. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma. Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731 [TBL] [Abstract][Full Text] [Related]
19. Effects of transpupillary thermotherapy on immunological parameters and apoptosis in a case of primary uveal melanoma. Schurmans LR; Blom DJ; De Waard-Siebinga I; Keunen JE; Prause JU; Jager MJ Melanoma Res; 1999 Jun; 9(3):297-302. PubMed ID: 10465586 [TBL] [Abstract][Full Text] [Related]